• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
In silico selectivity modeling of pyridine and pyrimidine based CYP11B1 and CYP11B2 inhibitors: A case study.基于吡啶和嘧啶的CYP11B1和CYP11B2抑制剂的计算机模拟选择性建模:一个案例研究。
J Mol Graph Model. 2022 Nov;116:108238. doi: 10.1016/j.jmgm.2022.108238. Epub 2022 Jun 1.
2
Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics.构建CYP11B家族的3D模型作为预测配体结合特征的工具。
J Comput Aided Mol Des. 2007 Aug;21(8):455-71. doi: 10.1007/s10822-007-9128-9. Epub 2007 Jul 24.
3
Conferring aldosterone synthesis to human CYP11B1 by replacing key amino acid residues with CYP11B2-specific ones.通过用CYP11B2特异性的关键氨基酸残基替换来赋予人CYP11B1醛固酮合成能力。
Eur J Biochem. 1998 Mar 15;252(3):458-66. doi: 10.1046/j.1432-1327.1998.2520458.x.
4
Exploring QSAR for CYP11B2 binding affinity and CYP11B2/CYP11B1 selectivity of diverse functional compounds using GFA and G/PLS techniques.运用 GFA 和 G/PLS 技术探索不同功能化合物与 CYP11B2 结合亲和力和 CYP11B2/CYP11B1 选择性的定量构效关系(QSAR)。
J Enzyme Inhib Med Chem. 2010 Jun;25(3):354-69. doi: 10.3109/14756360903179476.
5
The potential of targeting CYP11B.靶向CYP11B的潜力。
Expert Opin Ther Targets. 2016 Aug;20(8):923-34. doi: 10.1517/14728222.2016.1151873. Epub 2016 Mar 2.
6
Discovery of Novel Pyrazole-Based Selective Aldosterone Synthase (CYP11B2) Inhibitors: A New Template to Coordinate the Heme-Iron Motif of CYP11B2.新型吡唑基选择性醛固酮合酶(CYP11B2)抑制剂的发现:一种协调 CYP11B2 血红素-铁基序的新模板。
J Med Chem. 2018 Jul 12;61(13):5594-5608. doi: 10.1021/acs.jmedchem.8b00328. Epub 2018 Jun 22.
7
Combined pharmacophore modeling, 3D-QSAR, homology modeling and docking studies on CYP11B1 inhibitors.细胞色素P450 11B1抑制剂的联合药效团建模、三维定量构效关系、同源建模及对接研究
Molecules. 2015 Jan 9;20(1):1014-30. doi: 10.3390/molecules20011014.
8
Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for human.利用肾上腺匀浆开发CYP11B1和CYP11B2检测方法:猴作为人类替代物的实用性。
J Steroid Biochem Mol Biol. 2015 Nov;154:197-205. doi: 10.1016/j.jsbmb.2015.08.004. Epub 2015 Aug 21.
9
Functional maturation of the primate fetal adrenal in vivo: 3. Specific zonal localization and developmental regulation of CYP21A2 (P450c21) and CYP11B1/CYP11B2 (P450c11/aldosterone synthase) lead to integrated concept of zonal and temporal steroid biosynthesis.灵长类胎儿肾上腺在体内的功能成熟:3. CYP21A2(P450c21)和 CYP11B1/CYP11B2(P450c11/醛固酮合成酶)的特定区域定位和发育调控导致区域和时间性类固醇生物合成的整合概念。
Endocrinology. 1998 Dec;139(12):5144-50. doi: 10.1210/endo.139.12.6333.
10
Synthesis and evaluation of imidazolylmethylenetetrahydronaphthalenes and imidazolylmethyleneindanes: potent inhibitors of aldosterone synthase.咪唑基亚甲基四氢萘和咪唑基亚甲基茚满的合成与评价:醛固酮合酶的强效抑制剂
J Med Chem. 2005 Mar 24;48(6):1796-805. doi: 10.1021/jm049600p.

引用本文的文献

1
Investigation of the inhibitory effects of the telomere-targeted compounds on glutathione S-transferase P1.端粒靶向化合物对谷胱甘肽S-转移酶P1抑制作用的研究。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 15. doi: 10.1007/s00210-025-03882-w.
2
Multilayered screening for multi-targeted anti-Alzheimer's and anti-Parkinson's agents through structure-based pharmacophore modelling, MCDM, docking, molecular dynamics and DFT: a case study of HDAC4 inhibitors.通过基于结构的药效团建模、多准则决策方法、对接、分子动力学和密度泛函理论对多靶点抗阿尔茨海默病和抗帕金森病药物进行多层筛选:以HDAC4抑制剂为例
In Silico Pharmacol. 2025 Jan 21;13(1):16. doi: 10.1007/s40203-024-00302-4. eCollection 2025.
3
First report on exploration of structural features of natural compounds (NPACT database) for anti-breast cancer activity (MCF-7): QSAR-based virtual screening, molecular docking, ADMET, MD simulation, and DFT studies.
关于天然化合物结构特征探索(NPACT数据库)用于抗乳腺癌活性(MCF-7)的首次报告:基于定量构效关系的虚拟筛选、分子对接、药物代谢动力学/药物毒性预测、分子动力学模拟和密度泛函理论研究。
In Silico Pharmacol. 2024 Oct 19;12(2):92. doi: 10.1007/s40203-024-00266-5. eCollection 2024.
4
Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase.一种强效芳香化酶和醛固酮合酶双重抑制剂的发现。
ACS Pharmacol Transl Sci. 2023 Nov 23;6(12):1870-1883. doi: 10.1021/acsptsci.3c00183. eCollection 2023 Dec 8.
5
Cardiovascular risk assessments in patients with cortisol-producing adenoma: impact of clinical features and genetic characteristics.伴有皮质醇分泌腺瘤患者的心血管风险评估:临床特征和遗传特征的影响。
Heart Vessels. 2024 Jan;39(1):65-74. doi: 10.1007/s00380-023-02309-x. Epub 2023 Sep 11.
6
1,3,4-Oxadiazole: An Emerging Scaffold to Inhibit the Thymidine Phosphorylase as an Anticancer Agent.1,3,4-恶二唑:作为抗癌剂抑制胸苷磷酸化酶的新兴支架。
Curr Med Chem. 2024;31(38):6227-6250. doi: 10.2174/0929867331666230712113943.

基于吡啶和嘧啶的CYP11B1和CYP11B2抑制剂的计算机模拟选择性建模:一个案例研究。

In silico selectivity modeling of pyridine and pyrimidine based CYP11B1 and CYP11B2 inhibitors: A case study.

作者信息

Matore Balaji Wamanrao, Banjare Purusottam, Singh Jagadish, Roy Partha Pratim

机构信息

Department of Pharmacy, Guru GhasidasVishwavidyalaya (A Central University), Bilaspur, 495009, India.

Department of Pharmacy, Guru GhasidasVishwavidyalaya (A Central University), Bilaspur, 495009, India.

出版信息

J Mol Graph Model. 2022 Nov;116:108238. doi: 10.1016/j.jmgm.2022.108238. Epub 2022 Jun 1.

DOI:10.1016/j.jmgm.2022.108238
PMID:35691091
Abstract

of selective drug candidates for highly structural similar targets is a challenging task for researchers. The main objective of this study was to explore the selectivity modeling of pyridine and pyrimidine scaffold towards the highly homologous targets CYP11B1 and CYP11B2 enzymes by in silico (Molecular docking and QSAR) approaches. In this regard, a big dataset (n = 228) of CYP11B1 and CYP11B2 inhibitors were gathered and classified based on heterocyclic ring and the exhaustive analysis was carried out for pyridine and pyrimidinescaffolds. The LibDock algorithm was used to explore the binding pattern, screening, and identify the structural feature responsible for the selectivity of the ligands towards the studied targets. Finally, QSAR analysis was done to explore the correlation between various binding parameters and structural features responsible for the inhibitory activity and selectivity of the ligands in a quantitative way. The docking and QSAR analysis clearly revealed and distinguished the importance of structural features, functional groups attached for CYP11B2 and CYP11B1 selectivity for pyridine and pyrimidine analogs. Additionally, the docking analysis highlighted the differentiating amino acids residues for selectivity for ligands for each of the enzymes. The results obtained from this research work will be helpful in designing the selective CYP11B1/CYP11B2 inhibitors.

摘要

对于高度结构相似的靶点而言,筛选选择性药物候选物对研究人员来说是一项具有挑战性的任务。本研究的主要目的是通过计算机模拟(分子对接和定量构效关系)方法,探索吡啶和嘧啶支架对高度同源的靶点CYP11B1和CYP11B2酶的选择性建模。在这方面,收集了一个包含228种CYP11B1和CYP11B2抑制剂的大数据集,并根据杂环进行分类,同时对吡啶和嘧啶支架进行了详尽分析。使用LibDock算法来探索结合模式、进行筛选,并识别负责配体对所研究靶点选择性的结构特征。最后,进行定量构效关系分析,以定量方式探索各种结合参数与负责配体抑制活性和选择性的结构特征之间的相关性。对接和定量构效关系分析清楚地揭示并区分了结构特征、连接的官能团对吡啶和嘧啶类似物对CYP11B2和CYP11B1选择性的重要性。此外,对接分析突出了每种酶对配体选择性的差异氨基酸残基。从这项研究工作中获得的结果将有助于设计选择性CYP11B1/CYP11B2抑制剂。